Network Modularity in Breast Cancer Molecular Subtypes

被引:26
|
作者
Antonio Alcala-Corona, Sergio [1 ,2 ]
de Anda-Jauregui, Guillermo [1 ,3 ]
Espinal-Enriquez, Jesus [1 ,2 ]
Hernandez-Lemus, Enrique [1 ,2 ]
机构
[1] Natl Inst Genom Med, Computat Genom, Mexico City, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, DF, Mexico
[3] Univ North Dakota, Sch Med & Hlth Sci, Grand Forks, ND USA
关键词
network modularity; gene regulatory networks (GRN); breast cancer subtypes; pathway enrichment analysis; Functional modules; community structure; GENE-EXPRESSION PATTERNS; COMMUNITY STRUCTURE; COMPLEX NETWORKS; HISTOLOGIC GRADE; PATHWAY; SIGNATURE; RISK; IDENTIFICATION; CARCINOMAS; RECURRENCE;
D O I
10.3389/fphys.2017.00915
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Breast cancer is a heterogeneous and complex disease, a clear manifestation of this is its classification into different molecular subtypes. On the other hand, gene transcriptional networks may exhibit different modular structures that can be related to known biological processes. Thus, modular structures in transcriptional networks may be seen as manifestations of regulatory structures that tightly controls biological processes. In this work, we identify modular structures on gene transcriptional networks previously inferred from microarray data of molecular subtypes of breast cancer: luminal A, luminal B, basal, and HER2-enriched. We analyzed the modules (communities) found in each network to identify particular biological functions (described in the Gene Ontology database) associated to them. We further explored these modules and their associated functions to identify common and unique features that could allow a better level of description of breast cancer, particularly in the basal-like subtype, the most aggressive and poor prognosis manifestation. Our findings related to the immune system and a decrease in cell death-related processes in basal subtype could help to understand it and design strategies for its treatment.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Transcriptional Network Architecture of Breast Cancer Molecular Subtypes
    de Anda-Jauregui, Guillermo
    Velazquez-Caldelas, Tadeo E.
    Espinal-Enriquez, Jesus
    Hernandez-Lemus, Enrique
    [J]. FRONTIERS IN PHYSIOLOGY, 2016, 7
  • [2] Molecular subtypes of breast cancer
    Valla, Marit
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2018, 138 (16) : 1521 - 1521
  • [3] Molecular Subtypes of Breast Cancer
    Almarzooq, Raed
    Alrayes, Amal
    Alaradi, Husain
    Abdulla, Hussain
    [J]. BAHRAIN MEDICAL BULLETIN, 2018, 40 (04) : 222 - 225
  • [4] REVISION OF MOLECULAR BREAST CANCER SUBTYPES
    Tishchenko, Inna
    Riveros, Carlos
    Moscato, Pablo
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 17 - 18
  • [5] Molecular subtypes and survival in breast cancer
    Engstrom, Monica Jernberg
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (12-13) : 1173 - 1173
  • [6] Molecular subtypes in Tunisian breast cancer
    Frikha, M.
    Zouari, S.
    Fourati, N.
    Kallel, M.
    Elloumi, F.
    Bahri, M.
    Siala, W.
    Boudawara, T.
    Khanfir, A.
    Mnejja, W.
    Daoud, J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S28 - S28
  • [7] Molecular Subtypes of Breast Cancer: A Review for Breast Radiologists
    Johnson, Karen S.
    Conant, Emily F.
    Soo, Mary Scott
    [J]. JOURNAL OF BREAST IMAGING, 2021, 3 (01) : 12 - 24
  • [8] Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
    Dai, Xiaofeng
    Xiang, Liangjian
    Li, Ting
    Bai, Zhonghu
    [J]. JOURNAL OF CANCER, 2016, 7 (10): : 1281 - 1294
  • [9] Immunohistochemical and molecular subtypes of breast cancer in Nigeria
    Adebamowo, Clement A.
    Famooto, Ayotunde
    Ogundiran, Temidayo O.
    Aniagwu, Toyin
    Nkwodimmah, Chibuzor
    Akang, Effiong E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) : 183 - 188
  • [10] Molecular subtypes of male breast cancer by immunohistochemistry
    Li, Huiling
    Yang, Yumei
    Wang, Dapeng
    Li, Zhengtian
    Zhang, Dan
    Xu, Fengjuan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1670 - 1677